Your browser doesn't support javascript.
loading
Short-term outcome of endoscopic submucosal dissection using a clutch cutter for subepithelial lesions within the esophagogastric submucosa: a Japanese prospective observational study.
Akahoshi, Kazuya; Inamura, Kazuki; Akahoshi, Kazuaki; Osada, Shigeki; Tamura, Shinichi; Oishi, Yoshihiro; Oya, Masafumi; Koga, Hidenobu.
Afiliação
  • Akahoshi K; Endoscopy Center, Aso Iizuka Hospital, Iizuka, Japan.
  • Inamura K; Department of Gastroenterology, Aso Iizuka Hospital, Iizuka, Japan.
  • Akahoshi K; Endoscopy Center, Aso Iizuka Hospital, Iizuka, Japan.
  • Osada S; Department of Gastroenterology, Aso Iizuka Hospital, Iizuka, Japan.
  • Tamura S; Endoscopy Center, Aso Iizuka Hospital, Iizuka, Japan.
  • Oishi Y; Department of Pathology, Aso Iizuka Hospital, Iizuka, Japan.
  • Oya M; Department of Pathology, Aso Iizuka Hospital, Iizuka, Japan.
  • Koga H; Clinical Research Support Office, Aso Iizuka Hospital, Iizuka, Japan.
Clin Endosc ; 2024 Oct 10.
Article em En | MEDLINE | ID: mdl-39385518
ABSTRACT
Background/

Aims:

The efficacy and safety of endoscopic submucosal dissection using a clutch cutter (ESD-CC) for subepithelial lesions within the esophagogastric submucosa (SELEGSM) has not been investigated. This study aimed to assess the efficacy and safety of ESD-CC for the treatment of SELEGSM.

Methods:

This prospective study included 15 consecutive patients with 18 SELEGSMs diagnosed by endoscopic ultrasonography. The primary outcomes were short-term outcomes including en bloc resection rate, R0 resection rate, procedure time, and complication rate. The secondary outcome was final histological diagnosis.

Results:

Among the participants, 18 lesions were identified 12 in the stomach (nine patients) and six in the esophagus (six patients). The en bloc resection rate was 94.4% (17/18). The R0 resection rate was 88.9% (16/18). The median operating time was 39 min, and no instances of perforation or bleeding were observed. The final diagnoses of SELEGSM included six neuroendocrine tumors (33.3%), six granular cell tumors (33.3%), two ectopic pancreases (11.1%), one inflammatory fibroid polyp (5.6%), one leiomyoma (5.6%), one lipoma (5.6%), and one leiomyosarcoma (5.6%).

Conclusions:

ESD-CC appears to be a technically efficient and safe approach for SELEGSM resection, suggesting its potential as a valuable treatment option.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Endosc Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão País de publicação:

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Endosc Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão País de publicação: